Internal Medicine
RSSArticles
-
Investigators Use Personalized Modeling to Diagnose Hypertrophic Cardiomyopathy
Blended techniques could help clinicians draft more effective treatment plans.
-
FDA Modifies Authorizations for COVID-19 Therapeutics
In the face of the omicron onslaught, certain once-reliable monoclonal antibodies are not as effective.
-
Should the Cath Lab Be Activated?
How should one interpret the ECG in the figure? Should the cardiac cath lab be activated on the basis of this ECG?
-
Sotrovimab Injection
In vitro neutralization data, artificial intelligence modeling, and anecdotal reports suggest sotrovimab is effective against the omicron variant while the efficacy of other monoclonal antibodies appears to wane.
-
SARS-CoV-2 as a North American Zoonosis
COVID-19 has become a North American zoonosis endemic in the Northeastern white-tailed deer population. Whether it causes symptomatic infection is unclear, but most infections likely are subclinical, with viral shedding in nasal secretions and feces. Now that infection has become established in this animal group, it likely will spread easily.
-
Using Honey to Treat Coughs
In a meta-analysis, researchers found honey alleviates cough for patients with upper respiratory infections.
-
Diet and the Risk of Dementia
This prospective cohort study demonstrated an association between a high inflammatory potential diet and increased risk for incident dementia.
-
In Addition to Vaccination, Can More Be Done to Prevent Severe COVID-19?
Using data for more than 1.2 million Americans who completed primary vaccination against COVID-19, severe disease outcomes were rare; however, vaccinated persons aged ≥ 65 years with immunosuppression or other underlying conditions were found to be at higher risk.
-
Using Honey to Treat Coughs
In a meta-analysis, researchers found honey alleviates cough for patients with upper respiratory infections.
-
Nutritional Interventions for Prodromal Alzheimer’s Disease
Over a 36-month period, patients with prodromal Alzheimer’s disease who consumed Fortasyn Connect (Souvenaid), a nutraceutical drink, demonstrated a slower decline in cognitive functions vs. the control group.